First clinical expression of equine insect bite hypersensitivity is associated with co-sensitization to multiple Culicoides allergens.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
05
2021
accepted:
10
09
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
31
12
2021
Statut:
epublish
Résumé
Insect bite hypersensitivity (IBH) is an IgE-mediated allergic dermatitis in horses incited by salivary allergens from Culicoides spp. IBH does not occur in Iceland, as the causative agents are absent, however a high prevalence is seen in horses exported to Culicoides-rich environments. To study the natural course of sensitization to Culicoides allergens and identify the primary sensitizing allergen(s) in horses exported from Iceland utilizing a comprehensive panel of Culicoides recombinant (r-) allergens. IgE microarray profiling to 27 Culicoides r-allergens was conducted on 110 serological samples from horses imported to Switzerland from Iceland that subsequently developed IBH or remained healthy. Furthermore, a longitudinal study of 31 IBH horses determined IgE profiles the summer preceding first clinical signs of IBH (TIBH-1), the summer of first clinical signs (TIBH) and the following summer (TIBH+1). In a group of Icelandic horses residing in Sweden, effects of origin (born in Iceland or Sweden) and duration of IBH (<4 years, 4-7 years, >7 years) on Culicoides-specific IgE was evaluated. Sero-positivity rates and IgE levels were compared. At TIBH, horses were sensitized to a median of 11 r-allergens (range = 0-21), of which nine were major allergens. This was significantly higher than TIBH-1 (3, 0-16), as well as the healthy (1, 0-14) group. There was no significant increase between TIBH and TIBH+1(12, 0-23). IBH-affected horses exported from Iceland had a significantly higher degree of sensitization than those born in Europe, while duration of IBH did not significantly affect degree of sensitization. Significant sensitization is only detected in serum the year of first clinical signs of IBH. Horses become sensitized simultaneously to multiple Culicoides r-allergens, indicating that IgE-reactivity is due to co-sensitization rather than cross-reactivity between Culicoides allergens. Nine major first sensitizing r-allergens have been identified, which could be used for preventive allergen immunotherapy.
Sections du résumé
BACKGROUND
Insect bite hypersensitivity (IBH) is an IgE-mediated allergic dermatitis in horses incited by salivary allergens from Culicoides spp. IBH does not occur in Iceland, as the causative agents are absent, however a high prevalence is seen in horses exported to Culicoides-rich environments.
AIMS
To study the natural course of sensitization to Culicoides allergens and identify the primary sensitizing allergen(s) in horses exported from Iceland utilizing a comprehensive panel of Culicoides recombinant (r-) allergens.
METHOD
IgE microarray profiling to 27 Culicoides r-allergens was conducted on 110 serological samples from horses imported to Switzerland from Iceland that subsequently developed IBH or remained healthy. Furthermore, a longitudinal study of 31 IBH horses determined IgE profiles the summer preceding first clinical signs of IBH (TIBH-1), the summer of first clinical signs (TIBH) and the following summer (TIBH+1). In a group of Icelandic horses residing in Sweden, effects of origin (born in Iceland or Sweden) and duration of IBH (<4 years, 4-7 years, >7 years) on Culicoides-specific IgE was evaluated. Sero-positivity rates and IgE levels were compared.
RESULTS
At TIBH, horses were sensitized to a median of 11 r-allergens (range = 0-21), of which nine were major allergens. This was significantly higher than TIBH-1 (3, 0-16), as well as the healthy (1, 0-14) group. There was no significant increase between TIBH and TIBH+1(12, 0-23). IBH-affected horses exported from Iceland had a significantly higher degree of sensitization than those born in Europe, while duration of IBH did not significantly affect degree of sensitization.
CONCLUSION
Significant sensitization is only detected in serum the year of first clinical signs of IBH. Horses become sensitized simultaneously to multiple Culicoides r-allergens, indicating that IgE-reactivity is due to co-sensitization rather than cross-reactivity between Culicoides allergens. Nine major first sensitizing r-allergens have been identified, which could be used for preventive allergen immunotherapy.
Identifiants
pubmed: 34780496
doi: 10.1371/journal.pone.0257819
pii: PONE-D-21-15096
pmc: PMC8592417
doi:
Substances chimiques
Allergens
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0257819Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Vet Immunol Immunopathol. 2008 Nov 15;126(1-2):102-9
pubmed: 18676025
J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498
pubmed: 29221580
Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):156-70
pubmed: 16574245
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):86-99
pubmed: 33369572
Vet Immunol Immunopathol. 2010 Sep 15;137(1-2):76-83
pubmed: 20537727
Vet Immunol Immunopathol. 2010 Jan 15;133(1):40-50
pubmed: 19640590
Acta Vet Scand. 2018 Nov 3;60(1):69
pubmed: 30390694
J Vet Intern Med. 2019 Sep;33(5):2327-2335
pubmed: 31429513
PLoS One. 2015 Apr 22;10(4):e0122090
pubmed: 25901733
Vet Immunol Immunopathol. 2012 Oct 15;149(3-4):245-54
pubmed: 22906994
Mol Immunol. 2008 Feb;45(3):818-27
pubmed: 17669496
Acta Vet Scand. 2006 May 26;48:3
pubmed: 16987399
Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):200-9
pubmed: 21071100
Front Immunol. 2020 Jul 07;11:1368
pubmed: 32733455
BMC Vet Res. 2020 Aug 10;16(1):283
pubmed: 32778104
Int J Parasitol. 2009 Jan;39(2):243-50
pubmed: 18708061
Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):227-39
pubmed: 23561552
Equine Vet J. 1990 Jul;22(4):232-5
pubmed: 2209518
Vet Immunol Immunopathol. 2012 Jun 30;147(3-4):113-26
pubmed: 22575371
Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):94-103
pubmed: 18068808
Vet Dermatol. 2014 Feb;25(1):29-e10
pubmed: 24267396
Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):65-75
pubmed: 18082270
Sci Rep. 2019 Oct 23;9(1):15170
pubmed: 31645629
Clin Exp Allergy. 2013 Aug;43(8):889-901
pubmed: 23889243
Vet Immunol Immunopathol. 2011 Mar 15;140(1-2):63-74
pubmed: 21168921
J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261
pubmed: 30471304
Allergy. 2021 Apr;76(4):1147-1157
pubmed: 32780483
Vet Dermatol. 2018 Feb;29(1):51-e22
pubmed: 28980353
Front Immunol. 2019 Jan 17;9:3131
pubmed: 30705676
Vet J. 2013 Oct;198(1):141-7
pubmed: 23891138